An empirically derived short form of the Boston naming test
- PMID: 14590575
An empirically derived short form of the Boston naming test
Abstract
The Boston Naming Test (BNT) is one of the most commonly used tests of confrontation naming. The length of the test, particularly when administered to impaired patients, has prompted the derivation of several abbreviated forms. Short forms of the BNT have typically been equated in terms of difficulty, but not empirically derived for discriminating between normals and anomic patients. Furthermore, most reports to date have been limited in sample size and generalizability. The present study examined BNT data from a total of 1,044 subjects, including 719 normals and 325 patients with Alzheimer's disease (AD). Scores were calculated for the entire 60-item version as well as for eight previously reported short forms. The scores were examined for the effects of age, education, and gender, as well as for the ability of each form to discriminate between AD patients and normals. There was a significant effect of age, education, and gender on all previously published forms, and the short forms varied in their ability to discriminate between patients and controls. A stepwise discriminant analysis was conducted to empirically derive a new, gender-neutral short form with discriminability comparable to the full 60-item test. Norms from this sample on the empirically derived short form are reported.
Similar articles
-
[A shortened form of the Spanish Boston naming test: a useful tool for the diagnosis of Alzheimer's disease].Rev Neurol. 2001 Oct 1-15;33(7):624-7. Rev Neurol. 2001. PMID: 11784949 Spanish.
-
Determinants of confrontation naming performance.Arch Clin Neuropsychol. 1999 Aug;14(6):489-96. Arch Clin Neuropsychol. 1999. PMID: 14590576
-
Boston naming test short forms: a comparison of previous forms with new item response theory based forms.J Clin Exp Neuropsychol. 2004 Oct;26(7):891-902. doi: 10.1080/13803390490510716. J Clin Exp Neuropsychol. 2004. PMID: 15742540
-
Normative data on the Boston Naming Test and two equivalent 30-item short forms.Clin Neuropsychol. 2000 Nov;14(4):526-34. doi: 10.1076/clin.14.4.526.7204. Clin Neuropsychol. 2000. PMID: 11262721
-
An attenuation of the 'normal' category effect in patients with Alzheimer's disease: a review and bootstrap analysis.Brain Cogn. 2007 Mar;63(2):167-73. doi: 10.1016/j.bandc.2006.11.003. Epub 2006 Dec 28. Brain Cogn. 2007. PMID: 17196316 Review.
Cited by
-
Combined assessment of progressive apraxia of speech brain microstructure by diffusion tensor imaging tractography and multishell neurite orientation dispersion and density imaging.Brain Behav. 2024 Jan;14(1):e3346. doi: 10.1002/brb3.3346. Brain Behav. 2024. PMID: 38376044 Free PMC article.
-
Behavioral and Neuropsychiatric Differences Across Two Atypical Alzheimer's Disease Variants: Logopenic Progressive Aphasia and Posterior Cortical Atrophy.J Alzheimers Dis. 2024;97(2):895-908. doi: 10.3233/JAD-230652. J Alzheimers Dis. 2024. PMID: 38143349 Free PMC article.
-
Functional network collapse in neurodegenerative disease.bioRxiv [Preprint]. 2023 Dec 6:2023.12.01.569654. doi: 10.1101/2023.12.01.569654. bioRxiv. 2023. PMID: 38106054 Free PMC article. Preprint.
-
Amyloid and Tau PET Positivity in Progressive Agrammatic Aphasia and Apraxia of Speech.J Alzheimers Dis. 2023;96(4):1759-1765. doi: 10.3233/JAD-230912. J Alzheimers Dis. 2023. PMID: 38007664 Free PMC article.
-
Longitudinal characterization of patients with progressive apraxia of speech without clearly predominant phonetic or prosodic speech features.Brain Lang. 2023 Oct;245:105314. doi: 10.1016/j.bandl.2023.105314. Epub 2023 Aug 20. Brain Lang. 2023. PMID: 37607419